Kazunari Miyazawa

Papers

Total Citations

H-Index

About

Kazunari Miyazawa is a radiation oncologist whose research focuses on advancing stereotactic radiotherapy techniques, particularly for prostate cancer. His most cited work, a 2016 study on rectal toxicity after extremely hypofractionated radiotherapy (EHF-RT) using a non-isocentric robotic radiosurgery system, demonstrates his commitment to improving treatment precision and patient safety. This feasibility study evaluated toxicity outcomes in early-stage prostate cancer patients aged 50–84, establishing critical safety benchmarks for high-dose, ultra-short radiation regimens. With 7 citations, this paper contributes foundational data to the growing field of hypofractionation, where reducing treatment duration while maintaining efficacy is paramount. Miyazawa’s research addresses the delicate balance between tumor control and normal tissue sparing, a key challenge in modern radiotherapy. His work on robotic radiosurgery systems highlights his expertise in cutting-edge technology, offering insights into minimizing rectal side effects—a common concern for patients. For students and researchers, Miyazawa’s studies provide practical guidance on implementing advanced radiation techniques safely, underscoring the importance of rigorous toxicity assessment in clinical trials. His contributions help shape protocols that enhance patient quality of life during cancer treatment.